Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.
Article Title
The Effect of the RMAT Designation on Biotechnology Stock Prices, Drug Development Timelines and Outcomes: An Empirical Analysis
Authored by
Joab Williamson
University of Huddersfield, Huddersfield, UK and Faron Pharmaceuticals Ltd, Turku, Finland.
Alexander James Spicer
Spicer & Spicer Ltd, Cambridge, UK.
Pierre-Albert Colcomb
Ampleia, Paris, France.